495 related articles for article (PubMed ID: 23937614)
21. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
Hanebutt FL; Rolf N; Loesel A; Kuhlisch E; Siegert G; Knoefler R
Haemophilia; 2008 May; 14(3):524-30. PubMed ID: 18284449
[TBL] [Abstract][Full Text] [Related]
22. Poor response to desmopressin acetate (DDAVP) in children with Hermansky-Pudlak syndrome.
Cordova A; Barrios NJ; Ortiz I; Rivera E; Cadilla C; Santiago-Borrero PJ
Pediatr Blood Cancer; 2005 Jan; 44(1):51-4. PubMed ID: 15368543
[TBL] [Abstract][Full Text] [Related]
23. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
Mannucci PM
Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
[TBL] [Abstract][Full Text] [Related]
24. Menorrhagia and bleeding disorders in adolescent females.
Halimeh S
Hamostaseologie; 2012; 32(1):45-50. PubMed ID: 22127528
[TBL] [Abstract][Full Text] [Related]
25. Hyponatremia after desmopressin (DDAVP) use in pediatric patients with bleeding disorders undergoing surgeries.
Sharma R; Stein D
J Pediatr Hematol Oncol; 2014 Aug; 36(6):e371-5. PubMed ID: 24942016
[TBL] [Abstract][Full Text] [Related]
26. How do you treat bleeding disorders with desmopressin?
Ozgönenel B; Rajpurkar M; Lusher JM
Postgrad Med J; 2007 Mar; 83(977):159-63. PubMed ID: 17344569
[TBL] [Abstract][Full Text] [Related]
27. Desmopressin and other synthetic vasopressin analogues in cancer treatment.
Gomez DE; Ripoll GV; Girón S; Alonso DF
Bull Cancer; 2006 Feb; 93(2):E7-12. PubMed ID: 16517412
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of platelet dysfunction and response to DDAVP in patients with congenital platelet function defects. A double-blind placebo-controlled trial.
Rao AK; Ghosh S; Sun L; Yang X; Disa J; Pickens P; Polansky M
Thromb Haemost; 1995 Oct; 74(4):1071-8. PubMed ID: 8560416
[TBL] [Abstract][Full Text] [Related]
29. DDAVP (desmopressin; 1-deamino-cys-8-D-arginine-vasopressin) treatment in children with haemophilia B.
Ehl S; Severin T; Sutor AH
Br J Haematol; 2000 Dec; 111(4):1260-2. PubMed ID: 11167773
[TBL] [Abstract][Full Text] [Related]
30. [Thrombocytic alpha-delta-storage-pool-disease: shortening of bleeding time after infusion of 1-desamino-8-D-arginine vasopressin].
Kosch A; Kehrel B; Nowak-Göttl U; Häberle J; Jürgens H
Klin Padiatr; 1999; 211(4):198-200. PubMed ID: 10472549
[TBL] [Abstract][Full Text] [Related]
31. High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A.
Leissinger C; Becton D; Cornell C; Cox Gill J
Haemophilia; 2001 May; 7(3):258-66. PubMed ID: 11380629
[TBL] [Abstract][Full Text] [Related]
32. Adenotonsillectomy in patients with desmopressin responsive mild bleeding disorders: a review of the literature.
Dunn AL; Cox Gill J
Haemophilia; 2010 Sep; 16(5):711-6. PubMed ID: 20028423
[TBL] [Abstract][Full Text] [Related]
33. Desmopressin (dDAVP): a powerful general hemostatic agent?
Drouet L; Scrobohaci ML; Boudaoud S; Vilain G
Nouv Rev Fr Hematol (1978); 1989; 31(2):163-5. PubMed ID: 2528120
[No Abstract] [Full Text] [Related]
34. 1-Deamino-8-D-arginine-vasopressin--an alternative in the management of mild haemophilia A and von Willebrand's disease.
Niessner H; Korninger C
Wien Klin Wochenschr; 1983 Nov; 95(21):753-7. PubMed ID: 6424339
[TBL] [Abstract][Full Text] [Related]
35. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
36. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders.
Mannucci PM
Blood; 1988 Nov; 72(5):1449-55. PubMed ID: 3052622
[TBL] [Abstract][Full Text] [Related]
37. PFA-100 test in the detection of platelet dysfunction and monitoring DDAVP in a patient with liver cirrhosis undergoing inguinal hernia repair.
Vucelić D; Golubović M; Bjelović M
Srp Arh Celok Lek; 2012; 140(11-12):782-5. PubMed ID: 23350257
[TBL] [Abstract][Full Text] [Related]
38. [An inherited hemostatic disorder as the cause of menorrhagia].
Leebeek FW; Lotgering FK
Ned Tijdschr Geneeskd; 2002 Mar; 146(12):545-8. PubMed ID: 11938574
[TBL] [Abstract][Full Text] [Related]
39. Intranasal desmopressin (Octim): a safe and efficacious treatment option for children with bleeding disorders.
Khair K; Baker K; Mathias M; Burgess C; Liesner R
Haemophilia; 2007 Sep; 13(5):548-51. PubMed ID: 17880442
[TBL] [Abstract][Full Text] [Related]
40. Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance.
Castaman G; Tosetto A; Federici AB; Rodeghiero F
Thromb Haemost; 2011 Apr; 105(4):647-54. PubMed ID: 21264446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
